title: Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
authors.affiliation: Bacteriology department, Universitary Hospital, (Larrey St), Angers (49000), France. mljoly-guillou@chu-angers.fr
authors.forename: Marie-Laure
authors.initials: ML
authors.lastname: Joly-Guillou
authors.forename: Marie
authors.initials: M
authors.lastname: Kempf
authors.forename: Jean-Didier
authors.initials: JD
authors.lastname: Cavallo
authors.forename: Monique
authors.initials: M
authors.lastname: Chomarat
authors.forename: Luc
authors.initials: L
authors.lastname: Dubreuil
authors.forename: Jeanne
authors.initials: J
authors.lastname: Maugein
authors.forename: Claudette
authors.initials: C
authors.lastname: Muller-Serieys
authors.forename: Micheline
authors.initials: M
authors.lastname: Roussel-Delvallez
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016470:Bacteremia / Q000382:microbiology; D005602:France; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D015378:Imipenem / Q000494:pharmacology*; D000077731:Meropenem; D008826:Microbial Sensitivity Tests / Q000379:methods; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D010538:Peritonitis / Q000382:microbiology; D010878:Piperacillin / Q000494:pharmacology; D000077725:Piperacillin, Tazobactam Drug Combination; D018410:Pneumonia, Bacterial / Q000382:microbiology; D013845:Thienamycins / Q000494:pharmacology*; D014946:Wound Infection / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077725:Piperacillin, Tazobactam Drug Combination; D015378:Imipenem; D010397:Penicillanic Acid; D000077731:Meropenem; D010878:Piperacillin